Indivina 1 mg/2.5 mg
Indivina 1 mg/2.5 mg is a medicine authorised by Swissmedic under authorisation number 55288. The authorisation holder is Orion Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 April 2000 and the authorisation is valid without a time limit. ATC code G03FA12 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 55288 |
|---|---|
| Name | Indivina 1 mg/2.5 mg |
| Full name | Indivina 1 mg/2.5 mg, Tabletten |
| Authorisation holder | Orion Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G03FA12 |
| First authorisation | 17 April 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Indivina 1 mg/2.5 mg, Tabletten | B | 17 April 2000 |
| 2 | Indivina 1 mg/5 mg, Tabletten | B | 17 April 2000 |
| 4 | Indivina 2 mg/5 mg, Tabletten | B | 17 April 2000 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 3X28 | Tablette(n) | G03FA12 | 07.08.6. | B |
| 7 | 3X28 | Tablette(n) | G03FA12 | 07.08.6. | B |
| 15 | 3X28 | Tablette(n) | G03FA12 | 07.08.6. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Indivina 1 mg/2.5 mg authorised in Switzerland?
Yes. Indivina 1 mg/2.5 mg is authorised by Swissmedic under authorisation number 55288, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Indivina 1 mg/2.5 mg have?
Indivina 1 mg/2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Indivina 1 mg/2.5 mg?
The authorisation holder is Orion Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.